Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

International Stem Cell (ISCO.OB) updates Skin Care product Launch

ISCO.OB completed the launch of its new stem cell skin care product line and will move to a general marketing program.
  • Lifeline Skin Care products contain parthenogenetic stem cell extract delivering skin rejuvenation technology that could help, prevent and repair damaged skin?

The Bottom Line: Lifeline Skin Care is now ready to move forward to the next phase of distribution, which will commence 4/11. Sales to date have greatly exceeded expectations for the trial launch. The phase will consist initially of a customer solicitation conducted by internet and direct response marketing. We agree with Ken Aldrich, Chairman of ISCO; selling over 7,000 bottles through a very limited trial launch, represents a first step, but it would be imprudent to base projections of future sales or profits on a sample base of this size. ISCO.OB is up $0.14 to $1.48 or 10.45%.